Cargando…
免疫检查点抑制剂在小细胞肺癌治疗中的临床研究进展
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of e?ective treatment stra...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500500/ https://www.ncbi.nlm.nih.gov/pubmed/31014443 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |